- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nutritional Requirements in Japan
Total 1056 results
-
TakedaRecruitingHereditary Angioedema (HAE)Japan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
TakedaCompletedEssential Hypertension Complicated by Type 2 Diabetes MellitusJapan
-
NewAmsterdam PharmaCompletedDyslipidemia | Hypercholesterolemia | High CholesterolJapan
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Osaka UniversityActive, not recruitingChronic Kidney Disease Stage 5Japan
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
Translational Research Center for Medical Innovation...Osaka University; Ministry of Health, Labour and Welfare, Japan; Hiroshima UniversityCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
AstraZenecaCompleted
-
Novo Nordisk A/SCompleted
-
Daiichi Sankyo Co., Ltd.Completed
-
Eisai LimitedCompleted
-
Osaka UniversityUnknownDiabetes Mellitus, Type 2Japan
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedA Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Ono Pharmaceutical Co. LtdMSD K.K.Completed
-
Kyowa Kirin Co., Ltd.CompletedX-linked Hypophosphatemic Rickets/OsteomalaciaJapan
-
Kyoto UniversityPfizer; Kitasato University; Tokushima University; Tottori UniversityRecruiting
-
Takeshi MorimotoUniversity of the RyukyusCompletedCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
InSightecUnknown
-
Wafaa Mahmoud AminCairo UniversityCompletedOverweight and Obesity | Balance; DistortedSaudi Arabia
-
Chugai PharmaceuticalCompletedPrimary OsteoporosisJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
TakedaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationThe Research Foundation for Microbial Diseases of Osaka UniversityCompleted
-
PfizerCompletedPrader-Willi SyndromeJapan
-
Bispebjerg HospitalWorld Health Organization; International Network of Health Promoting Hospitals... and other collaboratorsCompletedSmoking | Obesity | Malnutrition | Excessive Drinking | Lack of Physical ActivityCanada, Croatia, Czechia, Denmark, Estonia, Indonesia, Japan, Malaysia, Slovenia, Taiwan, Thailand
-
Daiichi Sankyo Co., Ltd.CMIC Co, Ltd. JapanCompletedDiabetic Peripheral Neuropathic Pain | Post-herpetic NeuralgiaJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
National Cerebral and Cardiovascular CenterMinistry of Health, Labor and Welfare (Japan)TerminatedMyocardial Infarction | Impaired Glucose ToleranceJapan
-
AstraZenecaCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis | Tetanus | DiphtheriaJapan
-
Astellas Pharma IncCompletedChronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Ono Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedA Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisChronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan